GRIFOLS | GRF - Current Assets


GRIFOLS reported EUR5.35B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Alcon AG USD 6.62B 4M Jun/2026
Almirall EUR 747.1M 33.12M Jun/2026
Amadeus IT EUR 2.64B 5.6M Sep/2026
Amarin USD 612.88M 10.12M Sep/2026
argenx SE USD 8.07B 1.17B Jun/2026
AstraZeneca USD 31.45B 3.48B Sep/2026
Bayer EUR 39.6B 5.96B Sep/2026
Cie Automotive EUR 1.8B 6.22M Dec/2025
Demant DKK 10.2B 130M Jun/2026
Ence Energia y Celulosa EUR 407M 10.3M Sep/2026
Essilor EUR 11.24B 770M Jun/2026
Ferrovial EUR 6.81B 500M Jun/2026
Fresenius EUR 12.29B 678M Sep/2026
Fresenius Medical Care EUR 7.84B 150.6M Sep/2026
Genmab DKK 2.8B 228M Jun/2026
GlaxoSmithKline GBP 17.9B 336M Sep/2026
GRIFOLS EUR 5.35B 40M Sep/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Inditex EUR 15.7B 392M Jun/2026
Lakefront Biotherapeutics EUR 2.31B 751.38M Jun/2026
Merck EUR 15.14B 1.37B Sep/2026
Novartis USD 28.75B 1.4B Sep/2026
Philips EUR 10.51B 1.18B Sep/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sanofi EUR 33.21B 1.68B Sep/2026
Smith & Nephew USD 4.39B 240M Jun/2026
UCB EUR 6.05B 733M Dec/2025
Viscofan EUR 876.65M 14.22M Sep/2026